Shire Wins Glaxo’s Muscle in Bid to Kickstart Vyvanse Sales (Bloomberg)
March 31 (Bloomberg) -- Shire Plc gained GlaxoSmithKline Plc’s marketing power to spur sales of the Vyvanse attention- deficit drug for adults as its predecessor, Adderall, loses patent protection.
Tags: Adderall, Adults, Attention Deficit, Bid, Bloomberg, Glaxo, Glaxosmithkline, Glaxosmithkline Plc, Marketing Power, Marketing Sales, Patent Protection, Predecessor, Wins